Inside Scope

Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a…
Dec 16th, 2022 | 15:47

Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product

Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion. In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss: • What are the practical logistics when you work on a switch with a patient? • How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch? • Are there any situations where you would consider appealing an insurance decision and not switching? • What tests do you use to determine whether a patient is experiencing active disease before or after a switch? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit agau.gastro.org.